SMMTSummit Therapeutics Inc.
What is the market doing?
No clear lean: rangebound and moderately shorted.
Choppy, but holding above its 200-day average. Price is +6% vs its 200-day average.
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 0.6% since the previous count, up from 4.7% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SMMT is trading
Summit Therapeutics Inc. is −6.9% over the past year while the S&P 500 is +18%: 25 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +6.2%
vs 200-day average · close to trend
- RSI (14)
- 56
RSI (14) · neutral
- Below its 52-week high
- 33%
Below its 52-week high
Details›
- Last close2026-10-09
- $17.60
- 1 monthS&P 500 +2.7%
- +3.5%
- 1 yearS&P 500 +18%
- −6.9%
- 5 yearsS&P 500 +88%
- +175%
- vs 50-day average$15.43
- +14%
- 52-week high
- $26.38
- 52-week low
- $12.42
- Annualised volatility
- 87%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $104M
| Year | Return |
|---|---|
| 2026 (year to date) | +0.60% |
| 2025 | −2.0% |
| 2024 | +584% |
| 2023 | −39% |
| 2022 | +58% |
| 2021 | −43% |
| 2020 | +194% |
| 2019 | +39% |
| 2018 | −90% |
| 2017 | +29% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +12% |
| Feb | 10 | 5 of 10 | +6.4% |
| Mar | 10 | 4 of 10 | +4.2% |
| Apr | 10 | 5 of 10 | +2.1% |
| May | 10 | 6 of 10 | +11% |
| Jun | 10 | 3 of 10 | −11% |
| Jul | 11 | 6 of 11 | +5.7% |
| Aug | 11 | 6 of 11 | +0.81% |
| Sep | 11 | 5 of 11 | +11% |
| Oct | 11 | 4 of 11 | −4.1% |
| Nov | 10 | 3 of 10 | −2.1% |
| Dec | 10 | 4 of 10 | +38% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.